HSBP1L1
gene geneOn this page
Also known as FLJ10967MGC189743
Summary
HSBP1L1 (heat shock factor binding protein 1 like 1, HGNC:37243) is a protein-coding gene on chromosome 18q23, encoding Heat shock factor-binding protein 1-like protein 1 (C9JCN9).
Predicted to enable transcription corepressor activity. Predicted to be involved in cellular heat acclimation. Predicted to be active in cytosol and nucleus.
Source: NCBI Gene 440498 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 14 total — 1 pathogenic
- MANE Select transcript:
NM_001136180
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37243 |
| Approved symbol | HSBP1L1 |
| Name | heat shock factor binding protein 1 like 1 |
| Location | 18q23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10967, MGC189743 |
| Ensembl gene | ENSG00000226742 |
| Ensembl biotype | protein_coding |
| Entrez | 440498 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 3 protein_coding, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000451882, ENST00000587347, ENST00000589516, ENST00000590571, ENST00000592352, ENST00000903186, ENST00000903187
RefSeq mRNA: 1 — MANE Select: NM_001136180
NM_001136180
CCDS: CCDS45886
Canonical transcript exons
ENST00000451882 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001658638 | 79970440 | 79970822 |
| ENSE00001708485 | 79968089 | 79968183 |
| ENSE00001726525 | 79966612 | 79966678 |
| ENSE00002845667 | 79964643 | 79964786 |
Expression profiles
Bgee: expression breadth ubiquitous, 207 present calls, max score 97.07.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.9496 / max 329.8048, expressed in 1585 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 170917 | 14.6355 | 1579 |
| 208614 | 0.3142 | 147 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 97.07 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.82 | gold quality |
| right lobe of liver | UBERON:0001114 | 96.76 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.65 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 95.67 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 95.60 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.57 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.27 | gold quality |
| rectum | UBERON:0001052 | 94.99 | gold quality |
| transverse colon | UBERON:0001157 | 94.78 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.76 | gold quality |
| right uterine tube | UBERON:0001302 | 94.70 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.69 | gold quality |
| skin of abdomen | UBERON:0001416 | 94.53 | gold quality |
| upper arm skin | UBERON:0004263 | 94.53 | silver quality |
| body of pancreas | UBERON:0001150 | 94.45 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.45 | gold quality |
| cerebellum | UBERON:0002037 | 94.40 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.32 | gold quality |
| minor salivary gland | UBERON:0001830 | 94.11 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.80 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 93.70 | gold quality |
| skin of leg | UBERON:0001511 | 93.60 | gold quality |
| adrenal cortex | UBERON:0001235 | 93.47 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.38 | gold quality |
| right lung | UBERON:0002167 | 93.05 | gold quality |
| thyroid gland | UBERON:0002046 | 92.72 | gold quality |
| mouth mucosa | UBERON:0003729 | 92.70 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 92.54 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 92.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 19.76 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting HSBP1L1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-4761-5P | 99.51 | 66.69 | 804 |
| HSA-MIR-519D-5P | 99.41 | 69.30 | 2057 |
| HSA-MIR-6505-3P | 99.34 | 67.39 | 1071 |
| HSA-MIR-4483 | 98.09 | 64.12 | 1642 |
| HSA-MIR-4769-3P | 97.95 | 68.17 | 1002 |
| HSA-MIR-6817-5P | 97.95 | 67.86 | 1026 |
| HSA-MIR-1279 | 97.83 | 67.50 | 1898 |
| HSA-MIR-1293 | 96.16 | 64.69 | 916 |
| HSA-MIR-5002-3P | 95.75 | 67.04 | 542 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | hsbp1l1 | ENSDARG00000075984 |
| mus_musculus | Hsbp1l1 | ENSMUSG00000078963 |
| rattus_norvegicus | Hsbp1l1 | ENSRNOG00000059055 |
| drosophila_melanogaster | CG5446 | FBGN0032429 |
| caenorhabditis_elegans | WBGENE00002002 |
Paralogs (1): HSBP1 (ENSG00000230989)
Protein
Protein identifiers
Heat shock factor-binding protein 1-like protein 1 — C9JCN9 (reviewed: C9JCN9)
All UniProt accessions (2): C9JCN9, K7ENV5
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the HSBP1 family.
RefSeq proteins (1): NP_001129652* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009643 | HS1-bd | Family |
Pfam: PF06825
UniProt features (3 total): chain 1, coiled-coil region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-C9JCN9-F1 | 88.38 | 0.68 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 51 (showing top):
GOBP_CELLULAR_RESPONSE_TO_HEAT, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOBP_RESPONSE_TO_HEAT, GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY, GOBP_HEAT_ACCLIMATION, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, SNAI1_TARGET_GENES, SRSF9_TARGET_GENES, GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP, GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP, MIR4483, MIR1293, GOMF_MOLECULAR_ADAPTOR_ACTIVITY
GO Biological Process (2): cellular heat acclimation (GO:0070370), negative regulation of DNA-templated transcription (GO:0045892)
GO Molecular Function (2): transcription corepressor activity (GO:0003714), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| heat acclimation | 1 |
| cellular response to heat | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| transcription coregulator activity | 1 |
| negative regulation of DNA-templated transcription | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
338 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HSBP1L1 | HSPA4 | P34932 | 656 |
| HSBP1L1 | SLC66A2 | Q8N2U9 | 490 |
| HSBP1L1 | TXNL4A | P83876 | 482 |
| HSBP1L1 | IREB2 | P48200 | 467 |
| HSBP1L1 | RBFA | Q8N0V3 | 458 |
| HSBP1L1 | STOML2 | Q9UJZ1 | 449 |
| HSBP1L1 | SMS | P52788 | 440 |
| HSBP1L1 | FAM227A | F5H4B4 | 438 |
| HSBP1L1 | ARPP19 | P56211 | 434 |
| HSBP1L1 | CARS2 | Q9HA77 | 427 |
| HSBP1L1 | CARS1 | P49589 | 427 |
| HSBP1L1 | LPCAT3 | Q6P1A2 | 419 |
| HSBP1L1 | WASHC3 | Q9Y3C0 | 414 |
| HSBP1L1 | LAMTOR1 | Q6IAA8 | 410 |
| HSBP1L1 | GAPT | Q8N292 | 398 |
IntAct
32 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSBP1L1 | NFKBID | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | AGTRAP | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | ALAS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | PLP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | FKBP7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | SYNGR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | TNFRSF10D | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | MESD | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | CMTM4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | PBX4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSBP1L1 | AGTRAP | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSBP1L1 | ALAS1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSBP1L1 | PLP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSBP1L1 | FKBP7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSBP1L1 | SYNGR3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSBP1L1 | TNFRSF10D | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSBP1L1 | MESD | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSBP1L1 | CMTM4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSBP1L1 | PBX4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): HSBP1L1 (Affinity Capture-RNA), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid), HSBP1L1 (Two-hybrid)
ESM2 similar proteins: B2RXB2, B5X3I1, C9JCN9, D4A7N1, D4A9E1, O75506, P58686, Q0P4J3, Q0VCF3, Q13503, Q2NKS9, Q3TY65, Q3ZC22, Q4R6N3, Q4V7L5, Q5E9D3, Q5EAU9, Q5FWT9, Q5R561, Q5R8J5, Q5RDI2, Q5RE46, Q5RGJ6, Q5ZKJ4, Q66H15, Q68EW7, Q6DF11, Q6ID77, Q6IP02, Q6P255, Q6TA25, Q7SYL1, Q7T338, Q8AVR2, Q8GW48, Q8K3X8, Q8R0H9, Q99LE1, Q9BRQ6, Q9BRV8
Diamond homologs: B2RXB2, C9JCN9, D4A9E1, Q8GW48
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 4279287 | GRCh37/hg19 18q23(chr18:77685396-77744941)x1 | Pathogenic |
SpliceAI
1063 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:79964784:GCG:G | donor_gain | 0.9900 |
| 18:79964784:GCGGT:G | donor_loss | 0.9900 |
| 18:79964785:CGGTG:C | donor_loss | 0.9900 |
| 18:79964786:GGTGA:G | donor_loss | 0.9900 |
| 18:79964787:G:A | donor_loss | 0.9900 |
| 18:79964787:G:GG | donor_gain | 0.9900 |
| 18:79964788:T:G | donor_loss | 0.9900 |
| 18:79966736:G:GT | donor_gain | 0.9900 |
| 18:79967987:A:AG | acceptor_gain | 0.9900 |
| 18:79967988:A:G | acceptor_gain | 0.9900 |
| 18:79967990:A:AG | acceptor_gain | 0.9900 |
| 18:79967991:G:GG | acceptor_gain | 0.9900 |
| 18:79964739:G:GT | donor_gain | 0.9800 |
| 18:79965317:A:T | donor_gain | 0.9800 |
| 18:79965515:T:TA | acceptor_gain | 0.9800 |
| 18:79967991:GTT:G | acceptor_gain | 0.9800 |
| 18:79964781:G:GT | donor_gain | 0.9700 |
| 18:79964789:GA:G | donor_loss | 0.9700 |
| 18:79966758:T:TA | donor_gain | 0.9700 |
| 18:79966759:A:AA | donor_gain | 0.9700 |
| 18:79968045:C:CA | acceptor_gain | 0.9700 |
| 18:79965516:G:A | acceptor_gain | 0.9600 |
| 18:79970438:A:AG | acceptor_gain | 0.9600 |
| 18:79970439:G:GG | acceptor_gain | 0.9600 |
| 18:79965316:G:GT | donor_gain | 0.9500 |
| 18:79966676:G:GT | donor_gain | 0.9500 |
| 18:79966725:T:TA | donor_gain | 0.9500 |
| 18:79966726:A:AA | donor_gain | 0.9500 |
| 18:79967982:A:AG | acceptor_gain | 0.9500 |
| 18:79970435:A:G | acceptor_gain | 0.9500 |
AlphaMissense
486 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 18:79966634:T:C | L25P | 0.851 |
| 18:79966645:T:C | F29L | 0.842 |
| 18:79966647:T:A | F29L | 0.842 |
| 18:79966647:T:G | F29L | 0.842 |
| 18:79966655:T:C | L32P | 0.835 |
| 18:79968099:G:A | M43I | 0.832 |
| 18:79968099:G:C | M43I | 0.832 |
| 18:79968099:G:T | M43I | 0.832 |
| 18:79968151:G:C | A61P | 0.824 |
| 18:79968119:T:C | L50S | 0.819 |
| 18:79968107:G:C | R46P | 0.814 |
| 18:79966651:G:C | A31P | 0.794 |
| 18:79966667:T:C | L36S | 0.767 |
| 18:79968131:T:A | V54D | 0.760 |
| 18:79966646:T:C | F29S | 0.758 |
| 18:79968140:T:C | L57S | 0.719 |
| 18:79966660:G:C | A34P | 0.712 |
| 18:79968144:G:A | M58I | 0.711 |
| 18:79968144:G:C | M58I | 0.711 |
| 18:79968144:G:T | M58I | 0.711 |
| 18:79966646:T:G | F29C | 0.706 |
| 18:79966622:T:C | L21P | 0.696 |
| 18:79966612:G:C | A18P | 0.684 |
| 18:79966634:T:A | L25H | 0.637 |
| 18:79968155:G:T | G62V | 0.631 |
| 18:79966643:A:C | H28P | 0.625 |
| 18:79968110:T:A | I47N | 0.605 |
| 18:79968098:T:G | M43R | 0.598 |
| 18:79968110:T:G | I47S | 0.596 |
| 18:79968152:C:A | A61D | 0.593 |
dbSNP variants (sampled 300 via entrez): RS1000043686 (18:79969504 G>A), RS1000079281 (18:79965390 G>T), RS1001393359 (18:79964369 G>A,C), RS1001444695 (18:79969998 C>G), RS1001657849 (18:79964552 C>G), RS1003596581 (18:79966039 C>T), RS1003784879 (18:79971095 G>A), RS1003793025 (18:79969024 C>A), RS1003918184 (18:79965983 G>C), RS1004138997 (18:79965828 C>T), RS1005049427 (18:79966323 C>T), RS1005669407 (18:79968689 G>A,C), RS1006002880 (18:79967367 T>A), RS1006053870 (18:79967187 G>A,C), RS1006157852 (18:79963243 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases methylation | 3 |
| Acetaminophen | decreases expression | 2 |
| Estradiol | affects cotreatment, decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 2 |
| Cadmium Chloride | decreases expression, increases expression | 2 |
| GSK-J4 | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| incobotulinumtoxinA | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Ethanol | affects cotreatment, increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Gasoline | affects cotreatment, increases abundance, increases expression | 1 |
| Iron | decreases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | affects cotreatment, increases abundance, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Triclosan | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
| Particulate Matter | increases expression, affects cotreatment, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.